Skip to main content
. 2022 Apr 5;6(2):zrac022. doi: 10.1093/bjsopen/zrac022

Table 3.

Details in relation to sentinel lymph node biopsies, lymph node status, and axillary lymph node dissection

Parameter n (%)
Underwent SLNB 3156 (79.6)
Did not undergo SLNB 1200 (20.4)
SLNB− 3000 (95.1)
SLNB+ 153 (4.9)
Not reported 3 (<0.1)
Micrometastases 66 (43.1)
Macrometastases 47 (30.7)
Not reported 40 (26.1)
ITCs 26 (0.8)
ALND 148 (4.7)

SLNB, sentinel lymph node biopsy; ITCs, isolated tumour cells; ALND, axillary lymph node dissection.